Regardless of all new therapeutic advancements, a proportion of patients will however fail to respond and will be considered for curative therapy. At present, only allogeneic hematopoietic mobile transplantation may be viewed as potentially curative, but Additionally it is associated with sizeable morbidity and mortality. See "Qualified therapies in CLL: https://nicko665dsh2.activoblog.com/profile